Our research into rare cancers
Help us beat cancer sooner
Our life-saving work relies on the money you give us.
Donate now and together we can save more lives by beating cancer sooner.
Our research is saving lives
Together, rare cancers make up more than 20% of all cancer cases. We’ve contributed to several advances for people with rare cancers. We ran some of the first trials for people with uveal melanoma and neuroendocrine tumours, and showed that the drug Glivec was effective for some advanced gastro-intestinal stromal tumours (GIST). And we set up and continue to support the International Rare Cancers Initiative, which is developing clinical trials worldwide to find new treatments for rare cancers.